Both in Pharmaceuticals
Biofrontera vs Cellectar Biosciences INC NEW
Over the past year BFRI returned −19.4% and CLRB returned −64.6%; their daily moves had a correlation of 0.15.
BFRI −19.4% CLRB −64.6%Growth of $1, one year, split-adjusted
| Metric | BFRI | CLRB |
|---|---|---|
| Price | $0.8260 | $1.27 |
| Market cap | $12.3M | $12.0M |
| Today | +4.68% | +4.10% |
| 1 month | −30.0% | −29.4% |
| 6 months | −26.9% | −51.3% |
| Year to date | +44.9% | −56.9% |
| 1 year | −26.9% | −66.4% |
| Revenue growth (YoY) | +32.9% | — |
| Gross margin | 79.9% | — |
| Net margin | −5.0% | — |
| P/E (TTM) | — | — |
| Price / sales | 0.3× | — |
| Net cash | $47.0K | $34.0M |
| Dividend yield | — | — |
| Volatility (60d) | 74.0% | 67.6% |
| Short % of float | 1.3% | 1.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).